American Journal of Epidemiology, 151, 951–957.Ĭoupland, N. Antidepressant medication use and breast cancer risk. Archives of General Psychiatry, 43, 471–479.Ĭotterchio, M., Kreiger, N., Darlington, G., & Steingart, A. Combined psychotherapy and pharmacotherapy for depression: A systematic analysis of the evidence.
Antidepressant drugs and generic counseling for treatment of major depression in primary care: Randomized trial with patient preference arms. New York: HarperCollins.Ĭhilvers, C., Dewey, M., Fielding, K., Gretton, V., Miller, P., Palmer, B., et al. Hierarchical linear models: Applications and data analysis methods. Journal of Clinical Psychiatry, 67, 1776–1781.īryk, A. Antidepressants and driving ability: Results from a clinical study. Reducing suicidal ideation and depressive symptoms in depressed older primary care patients: A randomized controlled trial. Journal of Consulting and Clinical Psychology, 5, 877–884.īruce, M. Treatment of nonphobic anxiety disorders: A comparison of directive, nondirective, cognitive, and coping desensitization therapy. National Institute on Drug Abuse: Research Monograph Series, Mono, 140, 50–65.īorkovec, T.
Control groups and comparison groups in psychotherapy outcome research. San Antonio, TX: Psychological Corporation.īorkovec, T.
Manual for the Beck Depression Inventory-Fast Screen for medical patients. Use of Beck Anxiety and Beck Depression Inventories for Primary Care with medical outpatients. Behavior Research and Therapy, 35, 785–791.īeck, A. Screening for major depression disorders in medical inpatients with the Beck Depression Inventory for Primary Care. Psychotherapy and Psychosomatics, 63, 137–141.īeck, A. Risks and implications of interrupting maintenance psychotropic drug therapy. Open Psychology Journal, 1, 42–50.īaldessarini, R. Persistence of sexual dysfunction side effects after discontinuation of antidepressant medications: Emerging evidence. Psychotherapy and Psychosomatics, 72, 185–194.īahrick, A. Use of antidepressant medications and the possible association with breast cancer risk. A cost-effectiveness analysis of cognitive behavior therapy and fluoxetine (Prozac) in the treatment of depression. Psychotherapy and Psychosomatics, 68, 3–14.Īntonuccio, D.
Professional Psychology: Research and Practice, 26, 574–585.Īntonuccio, D. Psychotherapy vs medication for depression: Challenging the conventional wisdom with data. Antidepressants: A triumph of marketing over science? Prevention and Treatment, 5. Treating depressed children with antidepressants: More harm than benefit? Journal of Clinical Psychology in Medical Settings, 15, 92–97.Īntonuccio, D. Journal of Consulting and Clinical Psychology, 66, 685–690.Īntonuccio, D. Cognitive bibliotherapy for mild and moderate adolescent depressive symptomatology. This study provided empirical evidence that a behavioral prescription for Feeling Good may be as effective as standard care, which commonly involves an antidepressant prescription.Īckerson, J., Scogin, F., McKendree-Smith, N., & Lyman, R. Although not statistically significant, the mean net medical expenses in the behavioral prescription group were substantially less. Patients in both treatment groups reported statistically significant decreases in depression symptoms, decreases in dysfunctional attitudes, and increases in quality of life. The treatment groups did not differ in terms of overall outcome variables. Thirty-eight patients were randomly assigned to receive either usual care or a behavioral prescription to read the self-help book, Feeling Good (Burns, D. Six family physicians were trained to write and deliver prescriptions for cognitive-behavioral bibliotherapy. This study was designed to determine whether a physician-delivered bibliotherapy prescription would compare favorably with the prevailing usual care treatment for depression in primary care (that often involves medication) and potentially offer an alternative.